CELLforCURE, THE INDUSTRIAL PLAYER bringing YOUR CELL THERAPY PRODUCT UP TO MARKET.
Cell therapy, at the cellular of tomorrow's personalized medicine is expected to provide new ways of preventing or treating a wide range of diseases.
According to its customers and partners needs, in compliance with international regulatory requirements, CELLforCURE enables you :
- to industrialize and automate your autologous and/or allogeneic processes
- to produce your cell therapy products in industrial GMP facilities, from clinical to commercial scale
- to provide pharmaceutical and regulatory services, as well as pharmaceutical distribution of your cell therapy products.
Cellectis Enters into New Agreement with CELLforCURE
for the cGMP Manufacturing of UCART123 for Hematological Malignancies (see press release here attached - indicated below by "show")
CELLforCURE will have a booth at Cell and Gene Therapies B4B-Connection at Evry on February 3-4th, 2016.